Found 19 matching trials
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome PHASE3 The purpose of this study is to evaluate whether levetiracetam can prevent ...
Show More Location
Hospital Virgen de las Nieves
Learn More & Join Trial
A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers PHASE1 This study will estimate how fast two antiepileptic drugs (Levetiracetam an...
Show More Learn More & Join Trial
A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures PHASE3 A double-blind, randomized, multicenter, placebo controlled 5 parallel grou...
Show More Location
Multiple Locations
Learn More & Join Trial
Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint PHASE2 The main purpose of this study is to see whether brivaracetam has a faster ...
Show More Location
The Comprehensive Epilepsy Care Center For Children And Adults
Learn More & Join Trial
Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy PHASE2 Keppra injection is approved in the US as adjunctive therapy in the treatme...
Show More Location
Multiple Locations
Learn More & Join Trial
Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas PHASE4 Some patients with chronic subdural hematomas and transient neurological sy...
Show More Location
Centre Hospitalier Universitaire de Sherbrooke
Learn More & Join Trial
An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese PHASE1 The part A of N01362 is to evaluate the bioequivalence of Levetiracetam (LE...
Show More Learn More & Join Trial
Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175 (NCT00175903). PHASE3 For ethical reasons to give opportunity for adult subjects (≥16 or 18 years...
Show More Location
Multiple Locations
Learn More & Join Trial
Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures PHASE3 To demonstrate the non-inferiority of Levetiracetam (1000 mg/day) versus Ca...
Show More Learn More & Join Trial
Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs PHASE4 In this clinical trial patients with newly diagnosed focal epilepsy aged 60...
Show More Location
Department of Neurology, University of Mainz Medical Centre
Learn More & Join Trial